Quilter plc (LON:QLT – Get Free Report) shares fell 0.9% on Tuesday . The stock traded as low as GBX 128.50 ($1.72) and last traded at GBX 130 ($1.74). 398,115 shares were traded during mid-day trading, a decline of 85% from the average session volume of 2,589,063 shares. The stock had previously closed at GBX 131.20 ($1.76).
Wall Street Analysts Forecast Growth
Several equities analysts recently commented on QLT shares. Berenberg Bank upped their target price on shares of Quilter from GBX 105 ($1.41) to GBX 135 ($1.81) and gave the company a “hold” rating in a research note on Friday, August 9th. Citigroup upgraded shares of Quilter to a “neutral” rating in a research note on Friday, May 31st. Finally, JPMorgan Chase & Co. restated an “overweight” rating on shares of Quilter in a research note on Tuesday, September 3rd.
Read Our Latest Stock Analysis on QLT
Quilter Trading Down 0.9 %
Quilter Cuts Dividend
The firm also recently declared a dividend, which was paid on Monday, September 23rd. Investors of record on Thursday, August 29th were issued a dividend of GBX 1.70 ($0.02) per share. The ex-dividend date was Thursday, August 29th. This represents a yield of 1.33%. Quilter’s dividend payout ratio is 12,500.00%.
Quilter Company Profile
Quilter plc provides advice-led investment solutions in the United Kingdom and internationally. It operates through High Net Worth and Affluent segments. The High Net Worth segment provides discretionary investment management services to high-net worth clients, charities, companies, and institutions through a network of branches; and financial advice services for protection, mortgages, savings, investment, and pensions primarily to high-net-worth clients.
Further Reading
- Five stocks we like better than Quilter
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Are Penny Stocks a Good Fit for Your Portfolio?
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Quilter Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quilter and related companies with MarketBeat.com's FREE daily email newsletter.